Qui sommes-nous ? About us
L'ANSM en bref
About us
Nos engagements
Nos missions
Faciliter l'accès à l'innovation thérapeutique Assurer la sécurité des produits de santé Informer & échanger avec notre environnement
Notre périmètre
Les médicaments Les vaccins Les produits biologiques Les dispositifs médicaux et les dispositifs médicaux de diagnostic in vitro (DMDIV)
Notre organisation
Nos expertises Nos directions et nos services Nos instances
Déontologie et transparence
Nos exigences déontologiques Notre organisation de la déontologie Rapports du déontologue
Publications institutionnelles
Rapport d'activité 2024 Contrat d’objectifs et de performance Programmes de travail Rapports d'activité
Rejoignez-nous !
Nos métiers Notre politique RH Nos offres d'emploi
Notre agenda
 
Bulletin officiel des actes, décisions et avis
Décisions institutionnelles
Décisions relatives à l'organigramme Désignations et habilitations des inspecteurs Expertise : nomination d'experts ponctuels GIS Epiphare Instances : créations et nominations Nominations et délégations de signature
Décisions liées aux médicaments
Arrêts de commercialisation Accès dérogatoire Bonnes pratiques Classement substances vénéneuses (Listes I et II - Psychotropes/Stupéfiants) Médicaments biosimilaires Médicaments de médication officinale Médicaments génériques MTI et MTIPP Pharmacopée Programmes d'apprentissage Publicité Rétrocession Stocks de sécurité / Décisions d'interdictions d'exportation
Décisions liées aux produits sanguins et autres produits biologiques
Agréments établissements de transfusion sanguine Questionnaire pré-don
Décisions liées aux médicaments dérivés du plasma
Produits exclus de l'assiette de contribution
Décisions liées aux dispositifs médicaux et dispositifs médicaux de diagnostic in vitro
Agréments Calendrier publicité Organismes notifiés
Injonctions
Décisions de police sanitaire
Médicaments Dispositifs médicaux et dispositifs médicaux de diagnostic in vitro Autres produits
Sanctions financières
Avis
 
Disponibilité des produits de santé
Médicaments
Dispositifs médicaux et dispositifs médicaux de diagnostic in vitro
 
Vos démarches
Industriel
Organismes notifiés
Professionnel de santé
Patient
Chercheur
 
Expertises et publications scientifiques
Rapports d'enquêtes de vigilance
Publications scientifiques
  1. Retour

IncreaseNET 2026 Innovation & Competitiveness Summit – 15 October, 2026

PUBLIÉ LE 09/06/2026
A+ A-
print Télécharger le texte de cette page au format PDF

Registration form

The French medicine agency is pleased to announce a new innovation event, this time hosted in Paris, jointly organised by IncreaseNET and the EU-Innovation Network.
  • Date: 15 October 2026
  • Time: 09:00 – 17:00
  • Venue: Espace Hamelin, 17 Rue de l'Amiral Hamelin, 75116 Paris
Set against the broader context of European competitiveness, this conference will bring together key European and national actors involved in innovation support to explore early regulatory interaction, support for academia and SMEs, clinical trials and scientific & regulatory advice across Europe. It will also provide a space to discuss how to make this support landscape more visible, accessible and easier to navigate.                    

We will open the event with a welcome reception on the evening of 14 October 2026.
Participation details
  • Costs for in-person participation at the Innovation meeting (2 nights, 3 days) are covered for two representatives from each Beneficiary and Affiliated entity.
  • Online participation is available for all Beneficiaries, Affiliated entities, and Associated partners.
  • For Partners who are also EU-IN/BLCG members, IncreaseNET covers an additional 1 night and 1 day (total of 3 nights and 4 days) for participation at the EU-IN/BLCG face-to-face meetings. Please coordinate within your institution, as IncreaseNET covers costs for a maximum of two representatives per Partner (see above).
This event is co-funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or HaDEA. Neither the European Union nor the granting authority can be held responsible of them.
Please complete the registration form below for conference by July 15th, indicating your participation preferences:
  • Whether you will attend in person or virtually, and
  • If attending in person, whether you will join the welcome reception on 14 October and the Museum visit on 15 October.
You will receive a confirmation within the week once your registration has been completed. If you need to update your registration details, please contact us directly at elise.le-cloierec@ansm.sante.fr and aria.allahverdi@ansm.sante.fr

Program : 
  1. Wednesday, October 14, 2026 | 18:00 – 22:00: Welcome reception
  2. Thursday, October 15, 2026 | 8:30 – 9:00: Registration at the venue
  3. Thursday, October 15, 2026 | 9:00 – 17:00: Innovation & Competitiveness Summit as part of the Joint Action IncreaseNET
  4. Thursday, October 15, 2026 | 18:30 – 20:00: Orsay Museum visit
 

Registration for the Innovation & Competitiveness Summit – 15 October 2026

* Réponses obligatoires

Plusieurs réponses possibles

Aide
Consent for Name, Image, and Video Usage

By registering for this event, I understand and agree that:
  1. Participant list
    My name may be included in the list of participants, which may be shared for visibility purposes, such as in post-event articles or reports.
  2. Photograph and videos
    Photographs or videos taken during the event, including hybrid sessions, may feature me and may be used for event visibility, such as on the IncreaseNET webpage, social media, and related materials.
  3. Recordings
    The hybrid meeting will be recorded. These recordings may include audio, video, or images of participants and may be used for event reporting, training, and promotional purposes.
  4. Analytics and reporting
    Data collected during the event (e.g. registration information, participation patterns) may be used in aggregated and anonymized form for analytics and event evaluation purposes.